BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Rosiglitazone
,
rs4950928
,
PRKCA
,
calcium channel activity
,
Allergy to pollen
,
Neuron
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hormones tumor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Primary high-grade neuroendocrine carcinoma with positive steroid hormone receptors arising in the i…
ASSOCIATION OF miRNA EXPRESSION PATTERN WITH OUTCOME OF LETROZOLE THERAPY IN BREAST CANCER PATIENTS.
ASO Author Reflections: Prognostic Role of Preoperative Duke Pancreatic Monoclonal Antigen Type 2 Va…
Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast Cancer.
Significance of multiple tumor markers measurements in conversion surgery for unresectable locally a…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Interval Aerobic Training on Hormonal, Metabolic, and Tumor Markers in Postmenopausal
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Reducing Insulin, Growth Hormones, and Tumors
The Observational Study of Growth Hormone-secreting Pituitary Tumors
Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ